NCT04246554View on ClinicalTrials.gov

Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

October 9, 2020

Study Completion Date

January 1, 2021

Conditions
ACL InjuryPostoperative Pain
Interventions
DRUG

Ketorolac

Oral ketorolac for pain control following ACL reconstruction surgery

DRUG

Oxycodone-Acetaminophen

Oral oxycodone-acetaminophen for post-operative pain control

Trial Locations (1)

44106

UH Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT04246554 - Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery | Biotech Hunter | Biotech Hunter